Leukemia
Showing NaN - NaN of 132
Leukemia Trial in United States (arsenic trioxide, gemtuzumab ozogamicin, mercaptopurine)
Completed
- Leukemia
- arsenic trioxide
- +4 more
-
Roseville, California
- +191 more
Dec 14, 2022
Chronic Myelomonocytic Leukemia, Leukemia Trial in United States (Ruxolitinib)
Active, not recruiting
- Chronic Myelomonocytic Leukemia
- Leukemia
-
Tampa, Florida
- +4 more
Nov 11, 2022
Collecting and Storing Tissue From Young Patients With Cancer
Recruiting
- Acute Lymphoblastic Leukemia
- +13 more
- Cytology Specimen Collection Procedure
- Laboratory Biomarker Analysis
-
Birmingham, Alabama
- +68 more
Aug 4, 2022
Blood and Bone Marrow Samples in Chronic Myelogenous Leukemia
Active, not recruiting
- Leukemia
- DNA analysis
- +3 more
-
San Diego, California
- +160 more
Aug 2, 2022
Tissue and Blood Samples From Acute Myeloid Leukemia
Active, not recruiting
- Leukemia
- DNA analysis
- +7 more
-
Mountain View, California
- +76 more
Aug 2, 2022
Hematopoietic and Lymphoid System Tumor, Leukemia, Lymphoma Trial in Canada, United States (procedure, biological, other)
Active, not recruiting
- Hematopoietic and Lymphoid System Neoplasm
- +3 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +3 more
-
Birmingham, Alabama
- +42 more
Jul 20, 2022
Leukemia, Precursor b-Cell Lymphoblastic Leukemia-Lymphoma, ACUTE LYMPHOBLASTIC LEUKEMIA Trial in Worldwide (inotuzumab
Active, not recruiting
- Leukemia
- +2 more
- inotuzumab ozogamicin-dose level 2
- Inotuzumab ozogamicin-dose level 1
-
Los Angeles, California
- +45 more
Mar 9, 2022
Leukemia, Lymphoma, Blood Cancer Trial in Baltimore (Bone Marrow Transplant (BMT))
Recruiting
- Leukemia
- +5 more
- Bone Marrow Transplant (BMT)
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Feb 14, 2022
Leukemia Trial in Canada, United States (cytarabine, daunorubicin, midostaurin)
Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia
Active, not recruiting
- Leukemia
- +2 more
- laboratory biomarker analysis
-
San Diego, California
- +50 more
Aug 16, 2021
Leukemia Trial in United States (Azacitidine (AZA) Days 1 - 3, Decitabine (DAC), Best Supportive Care (BSC))
Active, not recruiting
- Leukemia
- Azacitidine (AZA) Days 1 - 3
- +3 more
-
Tampa, Florida
- +5 more
Jul 21, 2020
Leukemia Trial in Canada, United States (rituximab, fludarabine phosphate)
Terminated
- Leukemia
- rituximab
- fludarabine phosphate
-
Anniston, Alabama
- +386 more
Apr 9, 2020
Leukemia Trial in Canada, United States (biological, drug, other, procedure)
Completed
- Leukemia
- anti-thymocyte globulin
- +10 more
-
Birmingham, Alabama
- +51 more
Apr 7, 2020
Leukemia Trial in Baltimore (biological, drug, procedure)
Completed
- Leukemia
- filgrastim
- +10 more
-
Baltimore, MarylandGreenebaum Cancer Center at University of Maryland Medical Cente
Oct 31, 2019
Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in Baltimore (biological, drug, procedure)
Completed
- Leukemia
- +3 more
- daclizumab
- +4 more
-
Baltimore, MarylandMarlene & Stewart Greenebaum Cancer Center, University of Maryla
Oct 31, 2019
Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome Trial in Baltimore, New York
Completed
- Acute Myeloid Leukemia
- +7 more
-
Baltimore, Maryland
- +2 more
Oct 17, 2019
Leukemia, Lymphoma Trial in Baltimore (carmustine, cisplatin, cyclophosphamide)
Completed
- Leukemia
- Lymphoma
- carmustine
- +8 more
-
Baltimore, MarylandMarlene & Stewart Greenebaum Cancer Center, University of Maryla
Oct 15, 2019
Anemia, GVHD, Leukemia Trial in Baltimore (biological, drug, procedure, radiation)
Completed
- Anemia
- +5 more
- anti-thymocyte globulin
- +6 more
-
Baltimore, MarylandMarlene & Stewart Greenebaum Cancer Center, University of Maryla
Oct 15, 2019
Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in Baltimore (biological, drug, procedure, radiation)
Completed
- Leukemia
- +3 more
- anti-thymocyte globulin
- +5 more
-
Baltimore, MarylandMarlene & Stewart Greenebaum Cancer Center, University of Maryla
Oct 15, 2019